Silver nanoparticles (AgNPs), known for their effectiveness as antimicrobial agents, are now commonly used in the medical, household, and industrial sectors. Their efficacy against drug-resistant bacterial infections, as highlighted by Barros et al., underscores their potential in the realm of therapeutics (Barros et al., 2018). However, the cytotoxic impact of AgNPs on rat liver cells, as reported by recent studies, casts a shadow over their safety profile (Munger et al., 2014). Furthermore,